Author

I. Torre

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Implementation of hfa-icos risk score in patients with non-hodgkin lymphoma undergoing non-pegylated doxorubicin therapy

The HFA-ICOS score effectively stratifies mortality and cardiotoxicity risk among R-COMP–treated patients and supports its application in routine treatment of lymphomas requiring anthracycline-based therapy.

M. Camilli, I. Torre, L. Leo et al. · European Heart Journal, Supp... · 0 citations